Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial
ANNALS OF INTERNAL MEDICINE, vol.128, no.6, pp.443-451, 1998 (Journal Indexed in SCI)
Article / Article
Title of Journal :
ANNALS OF INTERNAL MEDICINE
Background: Recurrent oral and genital ulcers are the most frequent problem in the management of the Behcet syndrome. Uncontrolled experience suggests that thalidomide may help prevent recurrences of these ulcers.